ATS/ERS Statement on occupational burden of respiratory disease

P. Blanc (San Francisco, United States of America)

Source: International Congress 2019 – Occupational and epidemiology Grand Round
Session: Occupational and epidemiology Grand Round
Session type: Grand round
Number: 4900
Disease area: -

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Blanc (San Francisco, United States of America). ATS/ERS Statement on occupational burden of respiratory disease. International Congress 2019 – Occupational and epidemiology Grand Round

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Optimizing experimental research in respiratory diseases: an ERS Statement
Source: International Congress 2018 – Organoids and pluripotent stem cells
Year: 2018


ERS Statement: Smoking cessation in COPD and other pulmonary disorders
Source: International Congress 2015 – New advances in smoking cessation interventions
Year: 2015



ERS/ATS Policy Statement: what constitutes an adverse health effect of air pollution?
Source: International Congress 2017 – ERS publications: 2017 ERS guidelines and task forces
Year: 2017


Tele-monitoring of ventilator-dependent patients: a European Respiratory Society Statement
Source: Guideline 2017
Year: 2017

Tele-monitoring of ventilator-dependent patients: a European Respiratory Society Statement
Source: Eur Respir J 2016; 48: 648-663
Year: 2016




ERS/TSANZ Task Force Statement on the management of reproduction and pregnancy in women with airways diseases
Source: Eur Respir J, 55 (2) 1901208; 10.1183/13993003.01208-2019
Year: 2020



The Occupational Burden of Nonmalignant Respiratory Diseases. An Official American Thoracic Society and European Respiratory Society Statement
Source: Guideline 2019
Year: 2019

ERS Statement on standardisation of cardiopulmonary exercise testing (CPET) in chronic lung diseases
Source: International Congress 2019 – Clinical Year in review
Year: 2019


An official European Respiratory Society statement on physical activity in COPD
Source: Guideline 2014
Year: 2014

An official European Respiratory Society statement on physical activity in COPD
Source: Eur Respir J 2014; 44: 1521-1537
Year: 2014



ERS/TSANZ Statement on the management of reproduction and pregnancy in women with airways diseases
Source: Guideline 2020
Year: 2020

ERS statement on paediatric long-term noninvasive respiratory support
Source: Guideline 2022
Year: 2021

Guideline methodology in the ERS/ATS COPD exacerbation guidelines
Source: Annual Congress 2013 –Recommendations from the ERS/ATS Guideline on COPD Exacerbation Prevention
Year: 2013

International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Source: ERS Webinar 2020: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Year: 2020


International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma
Source: Eur Respir J 2014; 43: 343-373
Year: 2013



ERS/EAACI statement on adherence to international adult asthma guidelines
Source: Virtual Congress 2021 – ERS/EAACI statement on adherence to international adult asthma guidelines
Year: 2021

ERS/EAACI statement on adherence to international adult asthma guidelines
Source: Eur Respir Rev, 30 (161) 210132; 10.1183/16000617.0132-2021
Year: 2021



ERS/EAACI statement on adherence to international adult asthma guidelines
Source: Guideline 2021
Year: 2021

European Respiratory Society guidelines for the management of adult bronchiectasis
Source: Eur Respir J, 50 (3) 1700629; 10.1183/13993003.00629-2017
Year: 2017



European Respiratory Society guidelines for the management of adult bronchiectasis
Source: Guideline 2017
Year: 2017